Disinvestment in cancer care: a survey investigating European countries’ opinions and views-Reference-Cited by-同舟云学术

Disinvestment in cancer care: a survey investigating European countries’ opinions and views

Published:2018-03-12 Issue:6 Volume:28 Page:987-992
ISSN:1101-1262
Container-title:European Journal of Public Health
language:en
Short-container-title:

Author:

Specchia Maria Lucia¹,La Torre Giuseppe²,Calabrò Giovanna Elisa¹,Villari Paolo²,Grilli Roberto³,Federici Antonio⁴,Ricciardi Walter¹,de Waure Chiara⁵

Affiliation:

1. Section of Hygiene - Institute of Public Health, Università Cattolica del Sacro Cuore, IRCCS Fondazione Policlinico “Agostino Gemelli”, Rome, Italy

2. Department of Public Health and Infectious Diseases, Sapienza Università di Roma, Rome, Italy

3. Department of Clinical Governance, Local Health Authority of Reggio Emilia, Italy

4. General Directorate for Health Prevention, Ministry of Health, Rome, Italy

5. Department of Experimental Medicine, University of Perugia, Perugia, Italy

Funder

Italian National Centre for Disease Prevention and Control

Ministry of Health

Publisher

Oxford University Press (OUP)

Subject

Public Health, Environmental and Occupational Health

Link

http://academic.oup.com/eurpub/article-pdf/28/6/987/26640168/cky033.pdf

Reference31 articles.

1. Rational disinvestment;Donaldson;QJM: Monthly J Assoc Phys,2010

2. Using health technology assessment to support optimal use of technologies in current practice: the challenge of ‘;Henshall;Int J Technol Assess Health Care,2012

3. Exploring policy-makers’ perspectives on disinvestment from ineffective healthcare practices;Elshaug;Int J Technol Assess Health Care,2008

4. Reversals of established medical practices: evidence to abandon ship;Prasad;JAMA,2012

5. Guiding the process of health technology disinvestment;Ibargoyen-Roteta;Health Policy,2010

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. History of trastuzumab: a case study in health technology reassessment and natural disinvestment in Veneto Region;Frontiers in Pharmacology;2024-08-06

2. Patient request amplifies other determinants of providing low value care: A factorial survey experiment in physicians’ decision-making;2024-07-23

3. Clinical performance indicators for monitoring the management of cutaneous melanoma: a population-based perspective;Melanoma Research;2022-07-19

4. End-of-life care in cancer patients: how much drug therapy and how much palliative care? Record linkage study in Northern Italy;BMJ Open;2022-05

5. Quality management of cutaneous melanoma: impact on short-term outcomes and costs;European Journal of Dermatology;2021-12